PUBLISHER: Grand View Research | PRODUCT CODE: 1611523
PUBLISHER: Grand View Research | PRODUCT CODE: 1611523
The global wearable artificial organs market size is expected to reach USD 28.74 billion by 2030, registering a CAGR of 17.2% from 2025 to 2030, according to a new report by Grand View Research, Inc. Growing cases of transplant failure coupled with the increasing shortage of organ donors are creating massive growth opportunities for wearable artificial organs. Technological advancement in the field of 3D printing and artificial intelligence is creating new avenues for the market.
These devices are improving the patient's quality of life by allowing them to continue their routine activities while undergoing therapy or dialysis. The market is expected to witness several product launches and FDA approvals. For instance, in December 2019, the FDA approved Tandem Diabetes Care's Control-IQ artificial pancreas system. The device is an automatic insulin dosing system designed to deliver correction boluses. In August 2019, the FDA approved a MED-EL cochlear implant system for single-sided asymmetric hearing loss. This system is approved for use in children 5 years and older.
Increasing incidence of road accidents resulting in severe injuries also creates a demand for wearable artificial organs. According to the World Health Organization, approximately 1.4 million people die in a road accident every year, and around 20 to 50 million people suffer from non-fatal injuries.